(Q34488418)

2 August 2017

title

Structure-based drug design identifies polythiophenes as antiprion compounds (English)

1 reference

2 August 2017

12

Herbert Budka

0 references

Simone Hornemann

19

object named as

Simone Hornemann

1 reference

2 August 2017

Mario Nuvolone

6

0 references

Beat H Meier

object named as

Beat H Meier

17

0 references

Adriano Aguzzi

20

object named as

Adriano Aguzzi

1 reference

2 August 2017

15

Anja Böckmann

1 reference

2 August 2017

Uli S Herrmann

1

1 reference

2 August 2017

Anne K Schütz

2

1 reference

2 August 2017

Hamid Shirani

3

1 reference

2 August 2017

Danzhi Huang

4

1 reference

2 August 2017

Dino Saban

5

1 reference

2 August 2017

Bei Li

7

1 reference

2 August 2017

Boris Ballmer

8

1 reference

2 August 2017

Andreas K O Åslund

9

1 reference

2 August 2017

Jeffrey J Mason

10

1 reference

2 August 2017

Elisabeth Rushing

11

1 reference

2 August 2017

Herbert Budka

12

1 reference

2 August 2017

Sofie Nyström

13

1 reference

2 August 2017

Per Hammarström

14

1 reference

2 August 2017

Amedeo Caflisch

16

1 reference

2 August 2017

K Peter R Nilsson

18

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 August 2015

1 reference

Science Translational Medicine

2 August 2017

published in

1 reference

2 August 2017

volume

7

1 reference

2 August 2017

issue

299

1 reference

2 August 2017

page(s)

299ra123

1 reference

Novel proteinaceous infectious particles cause scrapie

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Protein aggregation diseases: pathogenicity and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Rapidly progressive dementias and the treatment of human prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Approaches to therapy of prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Complex polyamines: unique prion disaggregating compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Drug resistance confounding prion therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Continuous quinacrine treatment results in the formation of drug-resistant prions

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Quinacrine promotes replication and conformational mutation of chronic wasting disease prions

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

An analytical solution to the kinetics of breakable filament assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Synthesis of a regioregular zwitterionic conjugated oligoelectrolyte, usable as an optical probe for detection of amyloid fibril formation at acidic pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Conjugated polyelectrolytes--conformation-sensitive optical probes for staining and characterization of amyloid deposits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Conjugated polyelectrolytes: conformation-sensitive optical probes for detection of amyloid fibril formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Prion strain discrimination using luminescent conjugated polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

The structural basis for optimal performance of oligothiophene-based fluorescent amyloid ligands: conformational flexibility is essential for spectral assignment of a diversity of protein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Polythiophenes inhibit prion propagation by stabilizing prion protein (PrP) aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Atypical prion protein conformation in familial prion disease with PRNP P105T mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Quaternary structure of pathological prion protein as a determining factor of strain-specific prion replication dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

The physical relationship between infectivity and prion protein aggregates is strain-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

High-resolution structure of infectious prion protein: the final frontier

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Parallel in-register intermolecular β-sheet architectures for prion-seeded prion protein (PrP) amyloids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

The amyloid-Congo red interface at atomic resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

The HADDOCK web server for data-driven biomolecular docking

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Interactions between a luminescent conjugated polyelectrolyte and amyloid fibrils investigated with flow linear dichroism spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

VMD: visual molecular dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Evidence that the Transmission of One Source of Scrapie Agent to Hamsters Involves Separation of Agent Strains from a Mixture

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Evidence for assembly of prions with left-handed beta-helices into trimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

From conversion to aggregation: protofibril formation of the prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Pentameric thiophene-based ligands that spectrally discriminate amyloid-β and tau aggregates display distinct solvatochromism and viscosity-induced spectral shifts

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

All-atom empirical potential for molecular modeling and dynamics studies of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Comparison of simple potential functions for simulating liquid water

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Automation of the CHARMM General Force Field (CGenFF) I: bond perception and atom typing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Canonical sampling through velocity rescaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

THE weighted histogram analysis method for free-energy calculations on biomolecules. I. The method

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Prion protein interaction with the C-terminal SH3 domain of Grb2 studied using NMR and optical spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Prion protein library of recombinant constructs for structural biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Domain organization and structure-function relationship of the HET-s prion protein of Podospora anserina

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Amyloid fibrils of human prion protein are spun and woven from morphologically disordered aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

Molecular dynamics with coupling to an external bath

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB1923

10.1126/SCITRANSLMED.AAB1923

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference